Health and life sciences news releases, as the companies issue them.
All releases
26 recent releases from TMX Newsfile, newest first, refreshed every 5 minutes. This list follows a fixed rule; nothing in it is chosen, ranked or paid for. Times are Eastern.
Envoy Medical, a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming…
OS Therapies, the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that it has initiated a Conditional Marketing Authorisation Application (CMAA) process with the U.K. Medicines and…
Highlights: U.S. patent officially granted by the U.S. Patent Office on September 29, 2026 Covers core innovations underpinning TempraMed's VIVI Cap Smart™, which was launched earlier this yearStrengthens the Company's…
Quinsam is announcing its Q3/2026 results, with net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) versus net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) in Q3/2025.…
Lifordi Immunotherapeutics, Inc., a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, presented Phase 1 clinical data for…
KALA BIO, Inc. today announced preliminary unaudited financial results for the quarter ended September 30, 2026.Preliminary Third Quarter 2026 ResultsNet loss of approximately $0.8 million for the third quarter of 2026…
Rhelion Life Sciences Corp.CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…
Vaneltix Pharma, Inc. ("Vaneltix"), a biotechnology company focused on developing treatments addressing unmet needs in women's healthcare and urology and Hyloris Pharmaceuticals SA (Euronext Brussels: HYL) ("Hyloris") …
Phio Pharmaceuticals Corp. is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that clinical…
Psyched Wellness Ltd. (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products…
Telo Genomics Corp.TSXV: TELOOTCQB: TDSGFTMX Newsfile
Telo Genomics Corp., a leader in the development of diagnostic and prognostic tests based on three-dimensional analysis of telomeres (which are the ends of chromosomes), today announced that it closed a term loan…
Phio Pharmaceuticals Corp. is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that it will…
Doseology announces revocation of the management cease trade order ("MCTO") previously issued on October 29, 2026; and its intention to voluntarily adopt the Semi-Annual Reporting ("SAR") Pilot Program pursuant to…
iSpecimen, an online global marketplace connecting scientists who need biospecimens for medical research with a network of healthcare specimen providers, today announced that it completed, on November 2, 2026, the…
Digicann is pleased to announce that, further to its news release dated June 5, 2026, it has entered into a binding share exchange agreement (the "Definitive Agreement") dated October 31, 2026 and signed on November 4…
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"),…
Record quarterly revenue of $14.9 million, up 23% from Q2 2026 and 18% year-over-year.Ohio revenue up 37% year-over-year to $10.9 million, led by Fairfield and Company-grown flower.Operating cash flow of $2.4 million…
Herbal Dispatch, a cannabis commerce and international distribution platform, today issued a progress report on Hero Dispatch (herodispatch.com), the Company's medical cannabis program for Canadian Veterans, and…
Neural announces a change to its Board of Directors and provides updates regarding its previously announced transaction with CWE European Holdings Inc. ("CWE").Board of DirectorsThe Company announces that John Durfy has…
Rhelion, an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…
MustGrow Biologics Corp., a leading provider of biological and regenerative agriculture solutions, today announced the appointment of Kevin Helash as Chief Executive Officer, effective November 1, 2026.Mr. Helash brings…
Doseology, a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it was unable to file its annual audited financial statements, management's discussion…
CBD of Denver, Inc. (OTCID: CBDD) ("CBD of Denver" or the "Company") today outlined the strategic priorities for BioCannabis, its operating business in Northern Greece, following the commercial relaunch of the…
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company…
Doseology a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that Larry Latowsky has resigned as a director of the Company, effective immediately.About…